A pproximAtely 1 in 3 patients with epilepsy will not achieve seizure freedom with antiseizure medications alone. Uncontrolled seizures are estimated to account for 80% of the cost of epilepsy in the United States.
Such preliminary results suggest that some degree of prejudice may exist with regard to RES in older patients. Patients over age 60 may be less likely to be offered surgery due to misperceptions including: 1) the fear that older patients have higher incidences of comorbid medical conditions, which reduce the safety of surgery; 2) the association of an older age with a longer duration of epilepsy and therefore a lower likelihood of seizure freedom following RES; 3) concerns for postsurgical cognitive decline; and 4) the possibility that older patients may be less adaptable and, consequently, that seizure freedom following RES will be less likely to increase QOL.
We report on our experience with epilepsy surgery in patients over 60 years of age with focal onset epilepsy with regard to seizure freedom and life satisfaction after surgery. We sought to determine if an upper age limit should be imposed on surgical candidates with refractory focal onset seizures. We also sought to determine the factors motivating older patients to consider RES and the impact of surgery on life fulfillment.
methods patient selection
Patients over 60 years of age at the time of RES were identified from the University of California, Los Angeles (UCLA), surgical series database for the period from 1998 to 2013. Retrospective chart review established comorbidities at the time of surgery, surgery side, type of surgery, and postresection pathology. We also calculated Charlson Comorbidity Index scores and 10-year survival probabilities (using those scores) for each patient. 5, 6 A minimum of 1 year of postoperative follow-up was required for study inclusion.
presurgical and postsurgical evaluations
Presurgical evaluation of potential epilepsy surgery patients at UCLA includes continuous inpatient video electroencephalography (EEG) monitoring, MRI, FDG-PET, and (for potential temporal lobectomy candidates) the intracarotid sodium amobarbital procedure (Wada testing). Patients also typically undergo extensive neuropsychological testing, although such testing is not routinely performed in all patients following RES. None of the patients in this study underwent intracranial EEG recordings.
Following completion of the above workup, patients are presented at a multidisciplinary consensus epilepsy surgery conference attended by epileptologists, epilepsy surgeons, neuropsychologists, neuroradiologists, and nurse specialists. All available data are reviewed to determine the suitability of individual patients for RES and/or the need for further testing (for example, ictal SPECT and/ or magnetoencephalography). Patients are subsequently referred for RES if all information is congruent and there is a realistic expectation of seizure freedom and/or substantial seizure reduction from surgery in the absence of significant side effects or risks (for example, memory and/ or language impairment). At our institution no predetermined baseline cognitive level of performance is required to undergo RES. Histories of psychological disorders such as depression and/or anxiety do not necessarily exclude consideration for surgery. However, we require that those disorders be adequately treated at the time of RES. If there is any doubt about the adequate treatment of comorbid psychological disorders, a formal psychiatry evaluation and clearance are requested prior to RES.
Postoperative complications were extracted from the electronic medical record. A telephonic interview was conducted to determine seizure outcome. Outcome was classified according to the Engel classification system, 8 and Engel Classes I and II were considered good outcomes.
reasons for undergoing res and postsurgery life Fulfillment
Patients were asked about changes in health status, driving, and working after surgery. Motivation to consider surgery and reasons for delay were evaluated. The influence of seizure-related falls and injuries on decision making was assessed. Patients were also queried about falls after surgery. Patients were asked to describe what they believed to be their greatest challenge in facing RES. Telephonic interviews (conducted by S.D.) were guided by a structured questionnaire assessing the motivation to consider surgery, seizure freedom, and satisfaction with surgery. A modified Liverpool Life Fulfillment (LLF) tool was administered postoperatively to measure life changes in the spheres of health, aspects of postsurgical adjustment, and perceptions of health status following surgery. This scale was modified to an 8-question scale assessing patient perception of life fulfillment. 21 We excluded workrelated items in our scale given that many patients were already retired at the time of RES and did not return to work after surgery; therefore, the maximum possible score on our modified LLF tool was 32 (Table 1) .
statistical analysis
Data entry and statistical analysis were performed using IBM SPSS Statistics Version 19 (IBM Corp.). We used the Wilcoxon rank-sum test with continuity correction. A p value < 0.05 was considered statistically significant.
results demographics
Twelve patients (9 females and 3 males) with an age ≥ 60 years underwent RES during the study period. These 12 represented approximately 3% of adult RES cases during the study years. The majority of patients (9 [75%] of 12) were offered a standard anteromesial temporal lobe (AMTL) resection (8 right-sided and 1 left-sided). One patient underwent a left temporal lesionectomy sparing the mesial structures. One patient underwent a right temporal lesionectomy. One case involved the resection of a right frontal lesion. Pathology revealed focal cortical dysplasia in 1 patient (8.3%, including the 1 patient who underwent a right frontal lesionectomy), cavernous hemangiomas in 2 (13.3%), dual pathology (focal cortical dysplasia and mesial temporal sclerosis) in 1 (8.3%), astrocytoma/low-grade glioma in 2 (13.3%), and nonspecific gliosis in 5 (41.7%). Mean age at the time of RES was 65 ± 4.2 years (range 60-74 years). For the 11 patients who underwent temporal resections, the mean age was 65 ± 4.4 years. Mean age at seizure onset was 38.2 ± 13.8 years (range 21-61 years). It was slightly higher (39.7 ± 13.4 years) for the 11 patients with temporal lobe epilepsy. The mean duration of epilepsy prior to surgery was 26.9 ± 15.2 years (range 1-48 years) for the entire group. This parameter increased to 31.9 ± 10.7 years (range 8-48 years) for the 10 nonneoplastic patients. It was slightly lower (25.4 ± 14.9 years) for the 11 patients who underwent temporal resections.
One death due to an astrocytoma was recorded in the group. This patient died 20 months after surgery. However, at the time of death, he was free of disabling seizures following a right AMTL resection. Consequently, life satisfaction scores were calculated for the 11 remaining patients (Table 2) .
One patient with a brief history of refractory seizures due to a confirmed astrocytoma (WHO Grade III) underwent a right AMTL resection within 1 year of seizure onset. In the remaining 10 cases, in which there were delays to surgery, the reasons for not considering surgical therapy earlier were recorded: never being offered surgery ( 
preoperative Neuropsychological testing
Nine of the 12 patients in our cohort had available neuropsychological testing prior to RES. Full neuropsychological testing data for these 9 patients are available in . Nine (90%, including the patient with frontal lobe epilepsy) of the 10 patients who underwent delayed RES said they would have considered surgery earlier if they had the chance to remake the decision, including 1 patient who was not completely satisfied with her postoperative seizure outcome.
medical comorbidities
The majority of patients (9 [75%] of 12) had at least 1 preoperative medical comorbidity, including 8 (72.7%) of the 11 patients who underwent temporal resections (Tables  4 and 5 ). The mean Charlson Comorbidity Index score was 3.7 ± 1.3 (range 2-7) among all the patients. The mean score was almost identical when limited to the patients who underwent temporal resections (3.6 ± 1.4, range 2-7). The Charlson Comorbidity Index allowed a mean 10-year survival probability of 61.0% ± 26.8% (range 0-90%) to be calculated. Similar 10-year survival probabilities (61.7% ± 28.0%, range 0-90%) were obtained when the analysis was limited to patients with temporal lobe seizures.
Falls and fractures were an important reason to consider surgery in 6 (54.5%) of 11 patients interviewed postoperatively. However, the fall risk remained elevated after surgery, even in seizure-free patients. Seven (63.6%) of the 11 patients reported postoperative falls and injuries including fractures. The 2 patients suffering only nocturnal seizures had both suffered repeated fall-related injuries that resulted in a fractured arm and hip in 1 patient and lacerations in the other. However, none of these falls with resulting injuries were caused by seizures.
Postoperative Life Fulfillment Scores
Eleven patients were interviewed and scored for life satisfaction by utilizing the modified LLF tool. Following surgery, the mean LLF score was 26.7 ± 6 (range 10-31). The mean score was unchanged when the analysis was limited to the patients with temporal resections. Eight (72.7%) noted excellent satisfaction with their RES, with 5 (45.5%) noting postoperative improvements in overall health. The LLF scores tended to be better in patients whose duration of epilepsy was ≤ 30 years prior to RES (29 ± 1.9) than in those whose epilepsy was > 30 years (24.8 ± 7.8; Wilcoxon rank-sum test with continuity correction W = 24, p = 0.11). The LLF scores also tended to be higher in patients with an Engel Class I outcome (8 patients, mean LLF score 28.5 ± 2.3) versus those with an Engel Class II-IV outcome (3 patients, mean LLF score 22 ± 10.8; W = 14.5, p = 0.42). However, the differences in neither of these factors reached statistical significance.
Reasons for low LLF scores (≤ 33.1) included falls and fractures, mood swings, feeling socially isolated and/or lacking a close friend, poor general health, cognitive and memory problems, and poor family relationships. High LLF scores were reported even though no changes occurred in the spheres of driving and working. No patients who were unemployed prior to RES resumed working postoperatively. Only 1 patient who was not driving prior to RES resumed driving after surgery.
surgical complications
No postoperative complications were reported in 9 patients (75%), even though 7 (77.8%) of these 9 patients had at least 1 medical comorbidity at the time of RES. One patient (8.3%) had a mild complication (left eye swelling) that quickly resolved postoperatively. Two patients (16.7%) had more significant postoperative complications; 1 patient had postoperative left facial weakness and 1 had a cerebrospinal fluid leak that was subsequently repaired. Both of these patients completely recovered from their postoperative complications.
discussion
Our results show that RES can be safe and effective in patients with an age ≥ 60 years. More than 90% of patients in our cohort had a good surgical outcome, with 50% becoming completely seizure free. The majority (75%) had no postoperative complication, even though most of them had at least 1 medical comorbidity at the time of RES. Improved overall health at the time of follow-up was recorded for 72.7% of patients. Our series adds to a growing body of literature suggesting that older patients are just as likely to be rendered seizure free by RES and to encounter no greater surgical risk than their younger counterparts. Most of the previous studies have focused on patients over 45-50 years but younger than 60. Only 2 published studies have specifically reported on patients 60 years or older.
1,12
Age ranges over 45 years include upper age limits > 60 years in only a small number of studies. 20, 22 However, even including patients older than 60 years at the time of RES does not result in a significant reduction in the rate of postoperative seizure freedom or an increase in complication rates. 7, 16, 22 In addition to being safe and efficacious, RES also resulted in high life satisfaction in our older cohort. Almost three-fourths of the cohort noted excellent satisfaction with their RES, with almost half noting postoperative improvements in overall health. Liverpool Life Fulfillment scores tended to be higher in patients who underwent RES sooner rather than later (≤ 30 years after seizure onset) and had complete postoperative seizure freedom. Interestingly, we observed high LLF scores in older patients following RES 
even though no significant change occurred in the percentage that could drive and/or work postoperatively. No patients who were unemployed prior to RES sought employment after RES. Only 1 patient who was not driving prior to RES regained driving privileges postoperatively. In younger patients with epilepsy, employment and driving status are often considered to be among the most important aspects of life compromised by uncontrolled seizures. 10 This has caused previous researchers to specifically examine these 2 factors when attempting to measure psychosocial outcomes following RES. 13 However, our data suggest that such factors should be given significantly less weight when attempting to measure life fulfillment in older patients following RES. Many older patients with drug-resistant epilepsy may have already retired and have no plans to seek new employment, regardless of whether they achieve seizure freedom or not. Some older patients may have stopped driving for other reasons (for example, changes in vision, slowed reaction time caused by other medical comorbidities, and so forth). The older patients in our cohort failed to see these abilities as either goals of surgery or essential to their independence and identity. Rather, they focused on other positive aspects of surgery, including improvements in safety, seizure control, and medication reduction, when judging the success or failure of RES. In developing future QOL scales for people with epilepsy, it may be important to take age into consideration when judging the weights to ascribe to driving and working.
Another positive aspect of RES that may apply to older patients is a reduction in falls and resulting injuries. Such a benefit goes beyond a mere reduction in seizure-related falls and injuries. Previous research has shown that patients taking antiseizure drugs (especially enzyme inducers) are at increased risk of fractures, particularly when such drug exposure is prolonged. 19 Fractures may be more likely because of osteoporosis and lower bone mass caused by enzyme-inducing antiseizure drugs. 18 In addition, certain antiseizure drugs may interact with other medications that older patients are commonly prescribed, altering their serum levels. 11 This coupled with potential reduced hepatic and renal clearance in the elderly could increase the frequency of toxicity, result in unsteadiness and/or ataxia, and contribute to falls. When successful, RES may allow physicians to successfully reduce or eliminate some or all antiseizure drugs from an older patient's medication regimen. This, in turn, may substantially lower the risk of drug toxicity, osteoporosis, falls, and/or fractures. Such potential benefit deserves further study in larger cohorts of older patients following RES.
Our study was not without limitations. Given the relatively small number of patients with an age ≥ 60 years who had undergone RES during the study period, our study was not sufficiently powered to demonstrate more subtle statistical significance with many of our findings. We realize that a larger cohort of older patients, possibly through prospective multicenter collaborations, is needed to more definitively determine the improvements to specific QOL domains offered by RES. The retrospective and subjective nature of some QOL question and answer choices may have resulted in reporting bias, with the patients aiming to support the authors. The cohort in our study represents a series of selected patients offered surgery during the study period. We do not have access to data on older patients who were evaluated and subsequently excluded from undergoing RES, and we acknowledge this limitation. Among the 11 patients who underwent temporal resections, only 1 had a conventional left AMTL, with another having a left temporal lesionectomy sparing the mesial structures. There may have been a perceived reluctance to offer dominant temporal lobe resection to older patients; however, there was no deliberate bias. Therefore, the safety and efficacy of RES in older patients with dominant temporal lobe epilepsy cannot be as readily established from our data. Only 1 patient in our cohort underwent an extratemporal resection. Therefore, we cannot positively conclude that extratemporal lobe resective surgery is safe and effective in patients older than 60 years of age. Given that no patients in our cohort underwent intracranial monitoring, we cannot address the safety and/or efficacy of this diagnostic tool in older patients. Although all patients had follow-up for at least 1 year after RES, 4 patients had follow-up that was less than 2 years. Given that we did not administer the LLF tool to our older patients preoperatively, we cannot objectively assess for significant quantitative improvements in life fulfillment in our cohort. However, given that a majority of our patients reported excellent satisfaction with their surgery and would in hindsight undergo surgery sooner, we felt there were probably improvements. Given that neuropsychological testing is not routinely performed at our institution after RES (as many tests are not approved by insurance), we cannot comment on potential postoperative changes on objective measures of verbal and nonverbal memory in older patients.
Despite these limitations, the findings of our study deserve attention. Our cohort is one of the largest to show that older patients beyond the age of 60 benefit from RES. The procedure can be safe and effective and has the potential to increase life fulfillment in all patients regardless of age. Older patients are currently an underrepresented population in the epilepsy literature. It is possible that older patients are more carefully screened simply because of age and may be unjustly denied a life-enhancing treatment. This is particularly pertinent given that this population may experience greater morbidity from seizures and antiseizure medications. Given advances in surgical technique and the advent of newer, less invasive procedures such as real-time MR-guided stereotactic laser thermal ablation, 23 there are now fewer reasons to withhold this option from older patients. We owe it to all patients to look beyond age when considering the possibility of RES and to expand the demographics of those referred for comprehensive epilepsy evaluations to include the older patient.
conclusions
Resective epilepsy surgery can be safe, effective, and satisfying in patients aged 60 years or older. The majority (91.7%) of older patients who underwent RES at our institution had a good postsurgical outcome (Engel Class I-II). Half were completely seizure free (Engel Class IA), even though the majority had 1 or more medical comorbidities. Almost 75% of older patients noted excellent satisfaction with their RES, with many (45.5%) noting postoperative improvements in overall health. Our data demonstrate that advancing age by itself should not prohibit the consideration of RES.
acknowledgments
We thank Dror Berel for his assistance with the statistical analysis. Dr. Engel receives research support from the NIH (NINDS P01 NS002808 [PI] and NINDS R37 NS033310 [PI]), the Epilepsy Foundation, and from private donors. Dr. Fried has received an institutional grant from the National Institute of Neurological Disorders and Stroke (Grant Nos. R21 NS37897 and U01 NS42372).
references

